FierceBiotech 4th Drug Development Forum

This conference provides a unique networking opportunity, featuring insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies addressing the strategic and operational challenges in the following areas:

Deal-Making and Business Strategy – This track will highlight how to map out the right financing strategy for your company and share best practices for mitigating risks and unlocking the potential of partnerships, licensing deals, and MandA transactions

Product Development Strategy – This track will cover the end-to-end drug development process, focusing on early R and D, clinical development, and the complexities of product commercialization up through launch;

URLs:
Tickets https://go.evvnt.com/458817-0?pid=154
Brochure https://go.evvnt.com/458817-2?pid=154

Prices:
Early Bird Pricing Until Sept 13 - Pharma/Biotech: USD 1495.0,
Early Bird Pricing Until Sept 13 - Service Providers: USD 2695.0,
Early Bird Pricing Until Sept 13 - Academic/Government : USD 995.0,
Standard Pricing Pharma/Biotech: USD 1695.0,
Onsite Pricing Pharma/Biotech: USD 1895.0,
Standard Pricing Service Providers: USD 2695.0,
Onsite Pricing Service Providers: USD 2895.0

Speakers: Sandy Macrae, Pearl S. Huang, Lizabeth Leveille, James Robinson, Emily Minkow, Elliott M. Levy, M.D., David Weinreich, M.D., MBA, Molly Harper, Lotus Mallbris, M.D., Ph.D., Robert Bagdorf, M.D., M.B.A., Kleem Chaudhary, Ph.D., Rich Daly

Time: 8:00 am - 3:00 pm